BioSpace News Archive

Tevogen Bio, a clinical stage biotechnology company, announced that its investigational COVID-19 therapy, TVGN-489, demonstrated strong antiviral activity against SARS-CoV-2 in the preclinical study.

AAD, developer of rapid diagnostic and data systems, announced a $7M investment to grow the company’s platform for fast, point-of-care decisions in animal and human health, supporting One Health objectives to protect human, animal and environmental health.

The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) received notice of allowance for a patent from the United States Patent Office (USPO) for a medical countermeasure to organophosphate (OP) nerve agent exposure.

Annovis Bio CEO Maria Maccecchini, Ph.D. will deliver a corporate presentation at 3:10 p.m. ET on May 13, 2021.

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today the completion of the first surgeries with the TRULIFT Expandable Spacer System.

Korro Bio, Inc ., an RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Vineet Agarwal as Chief Financial Officer.

Jaguar Health, Inc. today announced that Company management will host a webcast on Monday, May 17, 2021 at 8:30 a.m. Eastern Time to review first-quarter 2021 financials and provide business updates.

Doximity, the leading digital platform for medical professionals, today announced an expansion of its executive leadership team with the appointment of Anna Bryson as Chief Financial Officer (CFO)

Amgen (NASDAQ:AMGN) today announced the presentation of four cardiovascular research abstracts, including final data from the Repatha® (evolocumab) open label extension trial of patients living with HIV who have high cholesterol, as well as new data from FOURIER evaluating biomarkers of major cardiovascular (CV) events

Consistent with its history of deceptive and unethical behavior, IQVIA (NYSE: IQV) yesterday issued a press release that mischaracterizes the nature of a recent procedural e-discovery ruling in Veeva Systems (NYSE: VEEV) antitrust case against IQVIA.